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A nanostructure-enabled fluorescence chip for monitoring cell secretion 
Abstract 
Herein a nanostructure-enabled fluorescence chip to monitor the cell secretion is reported for the first 
time. The fluorescence chip is based on nanostructured aluminum oxide or nanoporous anodic aluminum 
oxide (Nano-AAO), which can dramatically enhance the fluorescence signal compared to coverslip glass. 
As a proof of concept, transforming growth factor β1 (TGF-β1) secreted directly by pancreaticstellate 
(iTAF) cells in isolation and in co-culture with pancreatic cancer (capan-1) cells has been monitored by 
the sensors using a sandwich assay. It has been found that 10 ng/ml of TGFβ1 can be readily detected in 
the complexity of conditioned cell media. The successful detection of the TGFβ1 secreted by iTAF cells in 
conditioned media indicates the possibility of the fluorescence sensors to monitor the cell secretion in 
real time. 
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Abstract— Herein a nanostructure-enabled fluorescence chip 
to monitor the cell secretion is reported for the first time. The 
fluorescence chip is based on nanostructured aluminum oxide 
or nanoporous anodic aluminum oxide (Nano-AAO), which can 
dramatically enhance the fluorescence signal compared to 
coverslip glass. As a proof of concept, transforming growth 
factor 1 (TGF-β1) secreted directly by pancreaticstellate 
(iTAF) cells in isolation and in co-culture with pancreatic 
cancer (capan-1) cells has been monitored by the sensors using a 
sandwich assay. It has been found that 10 ng/ml of TGFβ1 can 
be readily detected in the complexity of conditioned cell media. 
The successful detection of the TGFβ1 secreted by iTAF cells in 
conditioned media indicates the possibility of the fluorescence 
sensors to monitor the cell secretion in real time. 
Index Terms— anodic aluminum oxide, fluorescence 
enhancement, pancreatic cancer, transforming growth factor. 
 
I. INTRODUCTION 
Secreted extracellular cues allow cells to communicate. 
This communication drives differentiation, proliferation and 
migration and results in organization of unique biological 
systems with physiological functions [1-2]. Secreted 
molecules carry information in the ligand-receptor 
interactions they stimulate as well as in their spatiotemporal 
concentration distributions. Diffusion, binding and turnover 
of secreted molecules can confine their presence within a 
local area. Furthermore, responding cells can be various 
distances away from signaling cells and can spatially express 
receptors, resulting in unique responses. Consequently, it is 
critical to create a technical platform to sense cellular 
communication at the subcellular level. Many secreted 
proteins are important direct functional mediators of 
intracellular signaling and act by initiating signaling through 
cell surface receptors [3]. Other secreted proteins work 
indirectly by altering the extracellular matrix (ECM) which 
affects various cellular processes (REF). Cell communication 
through secretion is important in several situations including 
during cancer metastasis. Cancer and stromal cells 
communicate by secreting growth factors or ECM modifying 
proteins. Growth factors often enhance migration by 
activating intracellular signaling related to motility and ECM 
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modifying proteins alter the ECM structure or stiffness, both 
of which result in cancer invasion and metastasis (REF). 
Herein, a nanotechnology-enabled fluorescence sensing 
platform is reported for the first time. The platform may 
offer a new avenue for in situ high-resolution extracellular 
sensing to monitor transforming growth factor 1 (TGF-β1) 
secreted by pancreatic stellate cells (iTAF). 
II. MATERIALS, DEVICE DESCRIPTION AND METHODS 
A. Materials and procedure for stimulating cell secretion  
Materials: 3-aminopropyltriethoxysilane (APTES) and 
glutaraldehyde (Grade I, 70 wt% in H2O) were purchased 
from Sigma-Aldrich. Monoclonal Antibody (eBio16TFB), 
purified TGF-β1 and fluorescently labeled streptavidin were 
all purchased from ThermoFisher Scientific. LEAF™ 
Purified anti-human/mouse TGF-β1 Antibody was purchased 
from Biolegend. 
Procedure for stimulating secretion of TGF-β1 from 
iTAF cells [4-6]: Conditioned media was prepared by 
growing cells (iTAF or/and capan-1 cells) to 60% 
confluency, removing the media, and adding 2 ml of fresh 
Dulbecco’s Modified Eagles Medium (DMEM) (Sigma 
Aldrich, St. Louis, MO, USA) with 10% fetal bovine serum 
(FBS) (Gibco, Grand Island, NY, USA), 2% glutamax 
(Gibco) and 1% penicillin/streptomycin (Gibco) and placed 
back into a 37°C incubator. After 48 hours the media was 
removed, placed in a 15 ml conical tube, and clarified at 
3000 x g for five minutes to remove cellular debris. The 
media was transferred 1.5 ml Eppendorf tubes and flash 
frozen with liquid nitrogen and stored in a -4°C freezer until 
ready for use. 
 
Figure 1: Sketch of the microwell chip to monitor the secretion of cells 
using Nano-AAO micropatterns to enhance the fluorescence signals. 
The surface of Nano-AAO micropatterns is chemically functionalized 
to facilitate the capture of the molecules (TGFβ1) secreted by the cells 
(iTAF). 
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B. Fluorescence sensor and its operational principle 
The schematic of arrayed microwells fabricated from 
SU8 on glass substrate is shown in Fig. 1. Inside each 
microwell, there are a number of nanostructured aluminum 
oxide or nanoporous anodic aluminum oxide (Nano-AAO) 
micropatterns (Nano-AAO micropatterns). The nano-AAO 
micropatterns, due to their fluorescence enhancement 
capability [7-9] in comparison with coverslip glass, are used 
as fluorescence sensors. The surface of the sensor is 
functionalized with TGF-β1 antibody (Fig. 1). When TGF-
β1 is secreted by iTAF cells, it binds to its antibody. A 
biotinylated detection antibody along with a fluorescently 
labeled streptavidin binds TGF-1 resulting in fluorescence 
signals can be observed. 
C. Sensor surface functionalization process and detection 
process 
Surface functionalization steps are briefly summarized as 
the following (Fig. 2).  The sensor surface is cleaned by air 
plasma cleaner (PDC-32G-HARRICK PLASMA). 
Aminopropyltriethoxy silane (APTES) reacts with hydroxyl 
groups on the surface of Nano-AAO. After heat treatment the 
silane binds through all three esters, making a more stable 
bond. Glutaraldhyde is a bifunctional aldehyde that attacks 
the amine group forming a Schiff base. The exposed 
aldehyde through the same reaction can tether the capture 
antibody to the Nano-AAO surface. Biotinylated detection 
antibody and fluorescent streptavidin are added to 
conditioned media that may or may not contain TGF-β1. The 
TGF-β1 binds to the capture antibody and the detection 
antibody binds to the TGF-β1 as done during ELISAs. The 
presence of TGF-β1 is then detected by fluorescence signal 
from labeled streptavidin that binds to the biotinylated 
detection antibody. 
 
Figure 2: Schematic showing the step-by-step surface functionalization 
of the fluorescence sensor to detect TGFβ1.  
 
III. EXPERIMENTAL RESULTS AND DISCUSSION 
A.  Sensor fabrication results 
The development of the sensors starts with fabricating 
Nano-AAO micropatterns on glass substrate. The process 
flow is the same as that reported before [9]. Briefly, a layer 
of Al with high purity (99.99%) is deposited on a glass 
substrate, followed by an anodization process to convert Al 
into Nano-AAO. Then the Nano-AAO micropatterns are 
fabricated by optical lithography and time-controlled wet 
etching process [10]. Thereafter the microwells with sizes 
from 750 µm to 1500 µm in diameter are fabricated from 
SU8, ensuring that each microwell contains several to tens of 
Nano-AAO micropatterns. A photo in Fig. 3a shows the SU8 
microwells of different sizes on a glass substrate. An optical 
micrograph of the Nano-AAO micropatterns with a size of 
30 µm in a microwell and a SEM images of the nanopores in 
the micropatterns are shown in Fig. 3b. 
  
Figure 3: (a) Photo of fabricated Nano-AAO micropatterns-based 
fluorescence sensors within SU8 microwells on glass substrate; (b) 
optical micrograph of the AAO micropatterns inside a microwell. Inset 
showing the nanopores in each Nano-AAO micropatterns. 
 
B. Detection of the purified TGFβ1 in buffer 
We first detected the fluorescence images of the purified 
TGF-β1, which are diluted in PBS buffer at the 
concentrations of 10 µg/ml, 1 µg/ml, 100 ng/ml, 10 ng/ml, 
and 1ng/ml, respectively. For the control, no TGF-β1 is 
added to the buffer.  
The measured fluorescence images for applying these 
concentrations are shown in Fig. 4(a-e), while the measured 
fluorescence image for applying the buffer is shown in Fig. 
4(f). The fluorescence images are taken with excitation 
power of 20 % and fixed exposure time of 200 ms. Clearly 
the higher concentration of TGF-β1, the brighter images. The 
fluorescence intensities along the cutline across the Nano-
AAO micropatterns are plotted in Fig. 4(g). As can be 
shown, the intensity for 1 ng/ml and control experiment is 
quite similar, while the intensity for 10 ng/ml is significantly 
larger than that of the control experiment. Hence it is 
anticipated that the detection limit of the sensor should be 
lower than 10 ng/ml. 
C. Control experiment  
In order to further verify the fluorescence signal is due to 
the binding the TGF-β1, some additional control experiments 





Figure 4: (a-e) Measured fluorescence images of the sensors for 
TGFβ1 in buffer at concentrations of 10 µg/ml, 1 µg/ml, 100 ng/ml, 
10 ng/ml, and 1ng/ml, respectively; (f) measured fluorescence image 
in the control experiments; (g) the corresponding fluorescence 




Figure 5:  (a-c) Measured fluorescence images of the sensors after the 
experimental steps described in the context; (d) the corresponding 
fluorescence intensities for (a-c) along the cutline shown in (a). 
In Fig. 5(a), 100 ng/ml purified TGF-β1 is applied on a 
functionalized Nano-AAO sensor surface, followed by the 
standard detection process as described in Fig. 2. In Fig. 
5(b), there is no detection antibody applied after the purified 
TGF-β1 is applied (100 ng/ml). In Fig. 5(c), no purified 
TGF-β1 is applied, hence, the sandwich assay cannot be 
realized for detection. The fluorescence images are taken 
with excitation power of 20 % and fixed exposure time of 
500ms. The fluorescence intensities for the three 
experiments are shown in Fig. 5(d).  As shown, only the 
nano-AAO sensor following the standard detection 
procedure (Fig. 3) with 100 ng/ml purified TGF-β1 has 
strong fluorescence signal. The other two experiments 
without realizing sandwich assay shows obvious low 
fluorescence intensity.  
D. Detection of the secreted TGF-β1 in real cell media 
sample  
Finally, the real cell media samples (i.e. conditioned 
media samples) by co-culturing iTAF cell and capan-1 cell 
are detected by the fluorescence sensors. Specifically, the 
original co-culture media are diluted to 10% and 1%.  For 
comparison, the cell medium samples from culturing iTAF 






Figure 6: Measured fluorescence images of the sensors: (a-c) 100% 
co-culture media, 10% diluted co-culture media, 1% diluted co-culture 
media; (d-e) media for culturing ITAF and Capain-1 alone, 
respectively; (f) control experiment;(g) the corresponding fluorescence 
intensities for (a-f) along the cutline shown in (a). 
 
In Fig. 6, original co-culture media sample and its diluted 
media samples are applied to the sensors instead of purified 
TGF-β1 sample. As shown in Fig. 6(a), the co-culture media 
sample, which is the 48 hours cell culture media of iTAF cell 
and capan-1 cell together, shows brightest fluorescence 
images. And the fluorescence images becomes less and less 
bright for the samples after 10% (Fig. 6(b)) and 1% (Fig. 
  
6(c)) dilution of the original sample. In Fig. 6(d), the 
measured fluorescence image is for the media sample from 
culturing ITAF cell for 48 hours alone. In Fig. 6(e), the 
measured fluorescence image is for the media sample from 
culturing capan-1 cell alone for 48 hours alone. In Fig. 6(f), 
the measured fluorescence image in control experiment, the 
same as the aforementioned control experiments. All the 
fluorescence images are taken with excitation power of 20% 
and fixed exposure time of 200 ms. The corresponding 
fluorescence intensities along the cutline shown in Fig. 6(a) 
are shown in Fig. 6(g). Again, the sensors, after being 
applied with original and 10% diluted co-culture media 
samples, clearly show higher fluorescence signals than those 
of other samples. When applied with the conditioned media 
sample from iTAF cell alone, the fluorescence intensity from 
the sensors is almost the same as that of the diluted samples 
(1% dilution) from the conditioned media co-culturing iTAF 
cells and capan-1 cells. The fluorescence intensity for 1% 





The detection of the transforming growth factor TGF-β1 
secreted by pancreatic stellate cells (iTAF) using a 
nanostructured aluminum oxide (Nano-AAO) enabled 
fluorescence sensors is reported for the first time. Using a 
sandwich assay, both purified TGF-β1 in buffer and TGF-β1 
secreted by ITAF cells in culture media have been detected 
successfully. It has been found that as low as 10 ng/ml TGF-
β1 in buffer can be readily detected. The high specificity of 
the sandwich assay as demonstrated in the control 
experiments and the detection of TGF-β1 in conditioned 
media indicate the possibility to monitor the cell secretion in 
real time using the fluorescence sensing platform.   
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